Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000534690 | SCV000649643 | uncertain significance | Dysferlinopathy | 2016-12-03 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine with arginine at codon 962 of the DYSF protein (p.Gly962Arg). The glycine residue is moderately conserved and there is a moderate physicochemical difference between glycine and arginine. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a DYSF-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may alter RNA splicing, but this prediction has not been confirmed by published transcriptional studies. In summary, this variant is a novel missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. |
EGL Genetic Diagnostics, |
RCV000732763 | SCV000860749 | uncertain significance | not provided | 2018-04-16 | criteria provided, single submitter | clinical testing |